Clinical Trials Directory

Trials / Completed

CompletedNCT04802369

Factors and Prognostic Significance of Impaired Exercise Tolerance in Women Over 40 With Arterial Hypertension

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
185 (actual)
Sponsor
Polish Mother Memorial Hospital Research Institute · Academic / Other
Sex
Female
Age
40 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The subject of the study is evaluation of factors affecting to exercise intolerance in spiroergometry in women over 40 years of age with hypertension and association and relationship between the parameters of physical performance and prognosis in this group of patients.

Detailed description

The 185 women over 40 years of age hospitalized for arterial hypertension in the Department of Cardiology will be included in the study, including: the study group who demonstrated maximal oxygen consumption measured during incremental exercise indexed per kilogram - VO2max\<17 ml/kg/min and a second group who presented VO2max\>17 ml/min/kg.Selected prognostic factors will be analyzed, among others: demographic data of the patient, physical examination, symptoms, etiology and history of arterial hypertension, co-morbidities, results of selected laboratory tests, selected electrocardiographic and echocardiographic data, patient's cooperation with the doctor, treatment applied, parameters in the spiroergometric study, non-invasive assessment for central arterial pressure waveform analysis and body mass analysis.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDiagnostic testsSelected prognostic factors will be analyzed, among others: demographic data of the patient, physical examination, symptoms, etiology and history of arterial hypertension, co-morbidities, results of selected laboratory tests, selected electrocardiographic and echocardiographic data, patient's cooperation with the doctor, treatment applied, parameters in the spiroergometric study, non-invasive assessment for central arterial pressure waveform analysis and body mass analysis.

Timeline

Start date
2019-02-01
Primary completion
2020-01-28
Completion
2021-02-28
First posted
2021-03-17
Last updated
2024-04-03

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT04802369. Inclusion in this directory is not an endorsement.